Literature DB >> 22696435

Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme.

Ulf Landmesser, Arnold von Eckardstein, John Kastelein, John Deanfield, Thomas F Lüscher.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22696435     DOI： 10.1093/eurheartj/ehs182

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  10 in total

1.  HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative.

Authors:  Seth S Martin; Arif A Khokhar; Heidi T May; Krishnaji R Kulkarni; Michael J Blaha; Parag H Joshi; Peter P Toth; Joseph B Muhlestein; Jeffrey L Anderson; Stacey Knight; Yan Li; John A Spertus; Steven R Jones
Journal:  Eur Heart J       Date:  2014-06-30       Impact factor: 29.983

Review 2.  Childhood obesity-related endothelial dysfunction: an update on pathophysiological mechanisms and diagnostic advancements.

Authors:  Luc Bruyndonckx; Vicky Y Hoymans; Katrien Lemmens; José Ramet; Christiaan J Vrints
Journal:  Pediatr Res       Date:  2016-02-11       Impact factor: 3.756

3.  In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption.

Authors:  Sheng-Ping Wang; Erin Daniels; Ying Chen; Jose Castro-Perez; Haihong Zhou; Karen O Akinsanya; Stephen F Previs; Thomas P Roddy; Douglas G Johns
Journal:  J Lipid Res       Date:  2013-07-29       Impact factor: 5.922

4.  ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.

Authors:  Judit Cubedo; Teresa Padró; Rodrigo Alonso; Pedro Mata; Lina Badimon
Journal:  J Lipid Res       Date:  2016-04-25       Impact factor: 5.922

5.  Aging affects high-density lipoprotein composition and function.

Authors:  Michael Holzer; Markus Trieb; Viktoria Konya; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  Biochim Biophys Acta       Date:  2013-06-20

6.  Impact of estimated HDL particle size via the ratio of HDL-C and apoprotein A-I on short-term prognosis of diabetic patients with stable coronary artery disease.

Authors:  Li-Feng Hong; Bo Yang; Song-Hui Luo; Jian-Jun Li
Journal:  J Geriatr Cardiol       Date:  2014-09       Impact factor: 3.327

7.  Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome.

Authors:  Catherine Gebhard; Eric Rhéaume; Colin Berry; Geneviève Brand; Anne-Elen Kernaleguen; Gabriel Théberge-Julien; Mohammad Afaque Alam; Candace Y W Lee; Laurianne Boileau; Malorie Chabot-Blanchet; Marie-Claude Guertin; Marc-André Lavoie; Jean Grégoire; Réda Ibrahim; Philippe L'Allier; Jean-Claude Tardif
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

8.  Tachometer for reverse cholesterol transport?

Authors:  Arnold Eckardstein
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

Review 9.  Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application.

Authors:  Fabian Linden; Gabriele Domschke; Christian Erbel; Mohammadreza Akhavanpoor; Hugo A Katus; Christian A Gleissner
Journal:  Front Physiol       Date:  2014-11-21       Impact factor: 4.566

10.  Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

Authors:  Michael Holzer; Peter Wolf; Martin Inzinger; Markus Trieb; Sanja Curcic; Lisa Pasterk; Wolfgang Weger; Akos Heinemann; Gunther Marsche
Journal:  J Invest Dermatol       Date:  2013-08-28       Impact factor: 8.551
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.